T-Therapeutics
UKEntry
2023
Hold
3yr
Status
Active
Who owns T-Therapeutics?
T-Therapeutics is currently owned by Cambridge Innovation Capital through CIC Fund II (2022 vintage), since 2023. Across its history, T-Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Cambridge Innovation CapitalCIC Fund II · 2022 · VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2023 · present
Sofinnova PartnersActive
2023 · present(3yr) · Sofinnova Capital X · 2021 · Life Sciences VC
BGFActive
2025 · present(1yr) · BGF · 2011 · Evergreen
More from CIC Fund II
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack T-Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy T-Therapeutics?
2 strategic and 118financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on T-Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue